Pathogenesis beyond the cancer clone (s) in multiple myeloma

G Bianchi, NC Munshi - Blood, The Journal of the American …, 2015 - ashpublications.org
Over the past 4 decades, basic research has provided crucial information regarding the cellular
and molecular biology of cancer. In particular, the relevance of cancer microenvironment …

The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition

G Bianchi, L Oliva, P Cascio, N Pengo… - Blood, The Journal …, 2009 - ashpublications.org
Proteasome inhibitors (PIs) are effective against multiple myeloma (MM), but the mechanisms
of action and bases of individual susceptibility remain unclear. Recent work linked PI …

Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back

G Bianchi, KC Anderson - CA: a cancer journal for clinicians, 2014 - Wiley Online Library
Giada Bianchi MD… Giada Bianchi MD… Reprinted with modifications from: Bianchi G, Ghobrial
I. Does my patient with a serum monoclonal spike have multiple myeloma? Hematol Oncol …

Progressively impaired proteasomal capacity during terminal plasma cell differentiation

S Cenci, A Mezghrani, P Cascio, G Bianchi… - The EMBO …, 2006 - embopress.org
After few days of intense immunoglobulin (Ig) secretion, most plasma cells undergo
apoptosis, thus ending the humoral immune response. We asked whether intrinsic factors link …

The long-term impact of the COVID-19 unemployment shock on life expectancy and mortality rates

F Bianchi, G Bianchi, D Song - Journal of Economic Dynamics and Control, 2023 - Elsevier
We adopt a time series approach to investigate the historical relation between unemployment,
life expectancy, and mortality rates. We fit Vector-autoregressions for the overall US …

Lenalidomide enhances immune checkpoint blockade-induced immune response in multiple myeloma

…, MK Samur, KB Cowens, S Paula, G Bianchi… - Clinical cancer …, 2015 - AACR
Purpose: PD-1/PD-L1 signaling promotes tumor growth while inhibiting effector cell–mediated
antitumor immune responses. Here, we assessed the impact of single and dual blockade …

[PDF][PDF] Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target

…, R Carrasco, M Bandi, T Hideshima, G Bianchi… - Cancer cell, 2009 - cell.com
Multiple myeloma (MM) remains incurable despite novel therapies, suggesting the need for
further identification of factors mediating tumorigenesis and drug resistance. Using both in …

Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)

M Ho, A Patel, CY Goh, M Moscvin, L Zhang, G Bianchi - Leukemia, 2020 - nature.com
Multiple myeloma (MM) is a highly heterogenous disease that exists along a continuous
disease spectrum starting with premalignant conditions monoclonal gammopathy of …

[HTML][HTML] AL amyloidosis: current chemotherapy and immune therapy treatment strategies: JACC: CardioOncology state-of-the-art review

G Bianchi, Y Zhang, RL Comenzo - JACC: CardioOncology, 2021 - Elsevier
Immunoglobulin light chain (AL) amyloidosis is an incurable plasma cell disorder characterized
by deposition of fibrils of misfolded immunoglobulin free light chains (FLC) in target …

[HTML][HTML] Targeting proteotoxic stress in cancer: a review of the role that protein quality control pathways play in oncogenesis

…, S Lindsay, D Bazou, CY Goh, C Hanley, G Bianchi… - Cancers, 2019 - mdpi.com
Despite significant advances in cancer diagnostics and therapeutics the majority of cancer
unfortunately remains incurable, which has led to continued research to better understand its …